ORKAOruka Therapeutics, Inc.

Healthcare
$80.14+202% 1Y

The financials

Oruka Therapeutics, Inc. by the numbers

The next results filing is expected around Nov 9, 2026, a quarter after the last one.

Oruka Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$50M−$28Mn/a
Net income−$41M−$25Mn/a
Diluted EPSn/a−$0.46n/a
On our screens:Most shorted stocks

Biotechnology

Ranks #181 of 194 by RyuScore

Compare peers
MIRM-3.2%
Mirum Pharmaceuticals, Inc.
COGT-0.45%
Cogent Biosciences, Inc.
CGON-1.4%
CG Oncology, Inc.
KOD+2.2%
Kodiak Sciences Inc.
PTCT-3.8%
PTC Therapeutics, Inc.
SRRK-1.2%
Scholar Rock Holding Corporation